PL2938349T3 - Kompozycja do zastosowania jako terapia wspomagająca do leczenia nowotworów - Google Patents

Kompozycja do zastosowania jako terapia wspomagająca do leczenia nowotworów

Info

Publication number
PL2938349T3
PL2938349T3 PL13828803T PL13828803T PL2938349T3 PL 2938349 T3 PL2938349 T3 PL 2938349T3 PL 13828803 T PL13828803 T PL 13828803T PL 13828803 T PL13828803 T PL 13828803T PL 2938349 T3 PL2938349 T3 PL 2938349T3
Authority
PL
Poland
Prior art keywords
tumours
treatment
composition
support therapy
therapy
Prior art date
Application number
PL13828803T
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of PL2938349T3 publication Critical patent/PL2938349T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13828803T 2012-12-31 2013-12-31 Kompozycja do zastosowania jako terapia wspomagająca do leczenia nowotworów PL2938349T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002270A ITMI20122270A1 (it) 2012-12-31 2012-12-31 Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
EP13828803.0A EP2938349B1 (en) 2012-12-31 2013-12-31 Composition for use as a support therapy for treatment of tumours
PCT/IB2013/002890 WO2014102595A1 (en) 2012-12-31 2013-12-31 Composition for use as a support therapy for treatment of tumours, aids and leukaemia

Publications (1)

Publication Number Publication Date
PL2938349T3 true PL2938349T3 (pl) 2018-08-31

Family

ID=47720684

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13828803T PL2938349T3 (pl) 2012-12-31 2013-12-31 Kompozycja do zastosowania jako terapia wspomagająca do leczenia nowotworów

Country Status (13)

Country Link
US (2) US10933105B2 (pl)
EP (2) EP3345611B1 (pl)
KR (1) KR102188696B1 (pl)
CN (1) CN105025908A (pl)
BR (1) BR112015015393A2 (pl)
CA (1) CA2896402A1 (pl)
DK (2) DK2938349T3 (pl)
ES (1) ES2668483T3 (pl)
IT (1) ITMI20122270A1 (pl)
PL (1) PL2938349T3 (pl)
PT (1) PT2938349T (pl)
RU (2) RU2674658C2 (pl)
WO (1) WO2014102595A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20122270A1 (it) 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
KR101693574B1 (ko) * 2014-09-23 2017-01-06 한국 한의학 연구원 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물
KR102244492B1 (ko) * 2020-10-21 2021-04-26 대한민국(관리부서:국립수산과학원) 신규 락토바실러스 속 균주 및 그의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950001449B1 (ko) * 1992-07-03 1995-02-24 풀무원식품주식회사 알로에를 주원료로 한 건강보조식품의 제조방법
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
PT1629850E (pt) * 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
US20060045887A1 (en) * 2004-08-25 2006-03-02 Gavish-Galilee Bio Applications Ltd. Mushroom extracts having anticancer activity
US7964571B2 (en) * 2004-12-09 2011-06-21 Egen, Inc. Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
US7329421B2 (en) * 2004-12-16 2008-02-12 Agashe Mandar Dnyaneshwar Process of manufacturing clear juice from the leaves of the Aloe vera plant
ITMI20051510A1 (it) 2005-08-02 2007-02-03 Proge Farm Srl Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
ITTO20070555A1 (it) * 2007-07-26 2009-01-27 Bioman S R L Biomassa arricchita in zinco, procedimento per la sua preparazione e prodotti probiotici, cosmetici, dietetici e nutraceutici comprendenti tale biomassa
ITBA20080008A1 (it) * 2008-02-22 2009-08-23 Michele Barone Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
IT1397566B1 (it) * 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
US20110117210A1 (en) * 2009-11-17 2011-05-19 Andrey Ugolkov Therapeutic treatment of human cancers using simple salts of zinc
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
ITMI20122270A1 (it) 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.

Also Published As

Publication number Publication date
ITMI20122270A1 (it) 2014-07-01
ES2668483T3 (es) 2018-05-18
RU2015124336A (ru) 2017-02-06
DK3345611T3 (da) 2020-11-30
RU2018141041A (ru) 2019-03-21
US10933105B2 (en) 2021-03-02
CA2896402A1 (en) 2014-07-03
CN105025908A (zh) 2015-11-04
EP2938349A1 (en) 2015-11-04
US20200197453A1 (en) 2020-06-25
RU2674658C2 (ru) 2018-12-12
EP3345611A1 (en) 2018-07-11
KR20150102102A (ko) 2015-09-04
EP2938349B1 (en) 2018-02-21
WO2014102595A1 (en) 2014-07-03
BR112015015393A2 (pt) 2017-07-11
PT2938349T (pt) 2018-04-26
EP3345611B1 (en) 2020-09-02
KR102188696B1 (ko) 2020-12-09
US20150343004A1 (en) 2015-12-03
DK2938349T3 (en) 2018-05-07

Similar Documents

Publication Publication Date Title
HRP20190046T1 (hr) Kombinirana terapija za liječenje raka
HRP20180939T1 (hr) Kombinirana terapija za liječenje multiple skleroze
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
EP2906208A4 (en) THERAPEUTIC TREATMENT
ZA201307036B (en) Treatment of solid tumours
EP2788378A4 (en) ASSOCIATION THERAPY FOR THE TREATMENT OF CANCER
EP2830633A4 (en) COMBINATION THERAPY FOR CANCER TREATMENT
HK1214128A1 (zh) 癌症的治療
GB201217892D0 (en) Treatment of cancer
IL275636A (en) Medical combination for cancer treatment
HK1204956A1 (en) Treatment of cancer
GB201420971D0 (en) Therapeutic composition
GB2502112B (en) Appliance for administering pain-relieving therapy
PL2938349T3 (pl) Kompozycja do zastosowania jako terapia wspomagająca do leczenia nowotworów
HUE047357T2 (hu) Gyógyászati kezelés
GB201217890D0 (en) Treatment of cancer
IL233495A0 (en) Combination for cancer treatment
GB201214237D0 (en) Novel therapeutic composition
GB201208296D0 (en) Treatment of cancer